Paclitaxel
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Intergroupe Francophone de Cancerologie Thoracique
Overview
Paclitaxel is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Paclitaxel clinical trials
Explore related
Medical disclaimer. This page summarizes research about Paclitaxel for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.